在初级前列腺癌治疗后高风险生化复发的流行病学

Ugo Giovanni Falagario1, Francesco Pellegrino2, Lars Björnebo3

  • 1Department of Molecular Medicine and Surgery (Solna), Karolinska Institute, Stockholm, Sweden; Department of Urology and Kidney Transplantation, University of Foggia, Foggia, Italy.

PubMed
概括

在前列腺癌 (PCa) 治疗后,高危生化复发 (HR-BCR) 的定义各不相同. 根据EMBARK标准确定一个高风险群体,但许多患有BCR的人没有发展HR-BCR,这表明需要精确的风险分层.